On va le faire un peu brut de décoffrage, sans analyse critique
(Je ne rougis pas, c’est du même niveau que dans les revues médicales sponsorisées gratuites que l’on reçoit chaque jour au cabinet)
J’ai trouvé 3 articles intéressants dans le numéro du jour de Circulation:
Murphy TP et al. Supervised Exercise Versus Primary Stenting for Claudication Resulting From Aortoiliac Peripheral Artery Disease: Six-Month Outcomes From the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) Study. Circulation. 2012;125:130-139, published online before print November 16 2011, doi:10.1161/CIRCULATIONAHA.111.075770
Granger CB, Armaganijan LV. Should Newer Oral Anticoagulants Be Used as First-Line Agents to Prevent Thromboembolism in Patients With Atrial Fibrillation and Risk Factors for Stroke or Thromboembolism?: Newer Oral Anticoagulants Should Be Used as First-Line Agents to Prevent Thromboembolism in Patients With Atrial Fibrillation and Risk Factors for Stroke or Thromboembolism. Circulation. 2012;125:159-164, doi:10.1161/CIRCULATIONAHA.111.031146
Ansell J. Should Newer Oral Anticoagulants Be Used as First-Line Agents to Prevent Thromboembolism in Patients With Atrial Fibrillation and Risk Factors for Stroke or Thromboembolism?: New Oral Anticoagulants Should Not Be Used as First-Line Agents to Prevent Thromboembolism in Patients With Atrial Fibrillation. Circulation. 2012;125:165-170, doi:10.1161/CIRCULATIONAHA.111.031153